Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis

• Daniel R. MoralesUniversity of Dundee
• Tatiana V. MacfarlaneUniversity of Dundee
• Thomas MacLennan MacDonaldUniversity of Dundee
• Jesper HallasUniversity of Southern Denmark
• Martin Thomsen ErnstUniversity of Southern Denmark
• Ron M. C. HeringsPharmo Institute
• Elisabeth SmitsPharmo Institute
• Jetty A. OverbeekPharmo Institute
• Lyn MitchellUniversity of Dundee
• S. V. MorantUniversity of Dundee
• Isla S. MackenzieUniversity of Dundee
• Alex S. F. DoneyUniversity of Dundee
• Chris RobertsonUniversity of Strathclyde
• Marion BennieUniversity of Strathclyde
• Li WeiUCL School of Pharmacy
• Lizzie NicholsonNational Health Service Scotland
• Carole MorrisNational Health Service Scotland
• Robert W. V. FlynnUniversity of Dundee